CDRH Unveils Its Collaborative Matrix Organization To Help Safety Reviews

FDA's device center has identified 13 collaborative product groups - or "matrix groups" - that will begin functioning in January to enhance its ability to make use of postmarket safety information

More from Archive

More from Medtech Insight